A Multicenter, Single-Arm, Prospective Phase II Clinical Study of Trastuzumab Rezetecan Combined With Radiotherapy in Patients With HER2-Mutated Oligoprogressive Advanced Non-Small Cell Lung Cancer
PHASE2
A Multicenter, Single-Arm, Prospective Phase II Clinical Study of Trastuzum...
Neoadjuvant Trastuzumab-rezetecan Plus Pertuzumab or Nab-Paclitaxel, Carboplatin, Trastuzumab, and Pyrotinib After Suboptimal Response to Neoadjuvant Dual HER2-Targeted Therapy Combined With Chemotherapy in HER2-Positive Early Breast Cancer
PHASE2
This prospective, response-guided phase II study investigates individualize...
Status
Recruiting
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Trastuzumab Rezetecan and Carboplatin ยฑ Bevacizumab Versus Investigator's Choice Chemotherapy in Patients With Platinum-sensitive Recurrent Ovarian Cancer
PHASE2
This study is a randomized, open-label, controlled phase II clinical trial....